Esthesioneuroblastoma chemotherapy and radiotherapy for extensive disease: a case report.

Abstract

Malignant tumors of the nasal cavity are rare. We report the case of a 48 years old man who consulted us with a 2-year history of progressive nasal obstruction, occasional epistaxis, facial pain, and watering of the eyes. A diagnosis of olfactory neuroblastoma was established by histopathology and confirmed by immunohistochemistry. On staging, the mass was classified as a Kadish stage C tumor with extensive involvement of the nasal cavities, nasopharynx, paranasal sinuses and orbit. Endoscopic excision of the mass was done. Traditionally the mainstay of treatment in such locally advanced patients is craniofacial resection followed by adjuvant radiotherapy. Our patient was treated with limited surgery and chemoradiation. Patient is free of recurrence at a follow-up of 5 years. This case report demonstrates the potential efficacy of planned combined modality therapy, including limited surgery and early chemoradiation in the control of locally advanced olfactory neuroblastoma.

• Authors: Seema Gupta, Nuzhat Husain, Sham Sundar
• Journal: World journal of surgical oncology (World J Surg Oncol) Vol. 9 Pg. 118 (Oct 05 2011) ISSN: 1477-7819 [Electronic] England
• PMID: 21974776 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antineoplastic Agents

Topics

• Antineoplastic Agents (therapeutic use)
• Combined Modality Therapy
• Esthesioneuroblastoma, Olfactory (pathology, surgery, therapy)
• Humans
• Male
• Middle Aged
• Nasal Cavity (pathology)
• Nose Neoplasms (pathology, surgery, therapy)
• Radiotherapy, Adjuvant
• Treatment Outcome